Key figures on U.S. public biotech companies 2012-2016

This statistic contains key figures on U.S. public biotech companies from 2012 to 2016. In 2016, U.S. public biotech companies generated some 112 billion U.S. dollars of revenue in total. In the same year, research and development spending came to nearly 39 billion dollars.

Key figures on U.S. public biotech companies from 2012 to 2016

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2017

Region

Worldwide

Survey time period

2012 to 2016

Supplementary notes

2012-2013 figures were added from previous editions of the report.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotech industry"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.